Report

Syndax Pharmaceuticals stock plunges after failed drug trial

Barron's reports the failed trial dealt a blow to the company's growth plans.

1 Source, 2h ago, first seen 2h ago

TLDR

Barron's reports that Syndax Pharmaceuticals' stock plunged and a failed drug trial dealt a blow to the company's growth plans.

Today's Rank

—

Not ranked yet

—

1 Source, first seen 2h ago

— likes— comments— saves— reposts

Positive——Negative

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source